# CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

> **NCT05238948** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 17 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** Midazolam
- **DRUG:** CKD-506

## Key facts

- **NCT ID:** NCT05238948
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-28
- **Primary completion:** 2022-04-29
- **Final completion:** 2022-04-29
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238948, "CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05238948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*